Despite recent advancements in chronic inflammatory demyelinating polyneuropathy (CIDP), significant challenges persist in its accurate diagnosis and optimal treatment. Throughout this program, Drs. Nicholas J. Silvestri, Christyn Edmundson, and Kelly G. Gwathmey will share their expertise, as they guide you through common electrodiagnostic and management pitfalls, outlining evidence-based approaches and drawing from their clinical experience with this rare disease. Through a close examination of guideline recommendations, our faculty will demonstrate strategies for the early recognition, accurate diagnosis, and contemporary treatment of CIDP. They will also explore treatment gaps, highlight individual patient needs, and provide crucial insights into the latest research on emerging mechanisms of action, such as complement and FcRn inhibitors, and newly approved delivery methods like facilitated subcutaneous immunoglobulins. This activity provides an opportunity both to stay updated on the most recent data of potentially transformative agents and learn how to improve patient outcomes using today’s therapeutic armamentarium.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://nexusmedx.motivelms.com/browse/preview/235
- Start Date: 2024-05-16 05:00:00
- End Date: 2024-05-16 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: Sanofi - Amount: 98763.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all